Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients.
作者信息
Valerio Luca, Ferrazzi Paola, Sacco Clara, Ruf Wolfram, Kucher Nils, Konstantinides Stavros V, Barco Stefano, Lodigiani Corrado
机构信息
Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany.
Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
出版信息
Thromb Haemost. 2021 Jan;121(1):98-101. doi: 10.1055/s-0040-1721317. Epub 2020 Nov 19.
Abstract
摘要
相似文献
1
Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients.
Thromb Haemost. 2021 Jan;121(1):98-101. doi: 10.1055/s-0040-1721317. Epub 2020 Nov 19.
2
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis.
J Thromb Thrombolysis. 2020 Oct;50(3):548-557. doi: 10.1007/s11239-020-02171-y.
3
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.
4
Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Infect Genet Evol. 2020 Nov;85:104511. doi: 10.1016/j.meegid.2020.104511. Epub 2020 Aug 26.
5
The role of D-dimer in relation to the clinical course of patients with COVID-19.
Acta Biochim Biophys Sin (Shanghai). 2021 Jan 12;53(1):119-120. doi: 10.1093/abbs/gmaa140.
6
D-Dimer Testing for the Exclusion of Pulmonary Embolism Among Hospitalized Patients With COVID-19.
JAMA Netw Open. 2021 Oct 1;4(10):e2128802. doi: 10.1001/jamanetworkopen.2021.28802.
7
Prognostic value of D-dimer/fibrinogen ratio on in-hospital outcomes of patients with heart failure and COVID-19.
Biomark Med. 2021 Nov;15(16):1519-1528. doi: 10.2217/bmm-2021-0341. Epub 2021 Oct 20.
8
Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City.
BMJ Open. 2020 Nov 27;10(11):e040736. doi: 10.1136/bmjopen-2020-040736.
9
Troponin and Other Biomarker Levels and Outcomes Among Patients Hospitalized With COVID-19: Derivation and Validation of the HAT COVID-19 Mortality Risk Score.
J Am Heart Assoc. 2021 Mar 16;10(6):e018477. doi: 10.1161/JAHA.120.018477. Epub 2020 Oct 30.
10
Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Biomark Med. 2021 Jun;15(8):541-549. doi: 10.2217/bmm-2020-0422. Epub 2021 May 14.
引用本文的文献
1
Role of peak D-dimer in predicting mortality and venous thromboembolism in COVID-19 patients.
Sci Prog. 2025 Jan-Mar;108(1):368504241247982. doi: 10.1177/00368504241247982.
2
Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.
Res Pract Thromb Haemost. 2023 Sep 16;7(7):102203. doi: 10.1016/j.rpth.2023.102203. eCollection 2023 Oct.
3
Temporal evolution of laboratory characteristics in patients critically ill with COVID‑19 admitted to the intensive care unit (Review).
Med Int (Lond). 2023 Sep 14;3(5):52. doi: 10.3892/mi.2023.112. eCollection 2023 Sep-Oct.
4
ACE2, ACE, DPPIV, PREP and CAT L enzymatic activities in COVID-19: imbalance of ACE2/ACE ratio and potential RAAS dysregulation in severe cases.
Inflamm Res. 2023 Aug;72(8):1719-1731. doi: 10.1007/s00011-023-01775-3. Epub 2023 Aug 3.
5
Mortality rates of severe COVID-19-related respiratory failure with and without extracorporeal membrane oxygenation in the Middle Ruhr Region of Germany.
Sci Rep. 2023 Mar 29;13(1):5143. doi: 10.1038/s41598-023-31944-7.
6
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19.
Diagnostics (Basel). 2023 Jan 7;13(2):224. doi: 10.3390/diagnostics13020224.
7
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.
Thromb J. 2022 Aug 29;20(1):48. doi: 10.1186/s12959-022-00403-0.
8
D-dimer testing in clinical practice in the era of COVID-19.
Res Pract Thromb Haemost. 2022 May 25;6(4):e12730. doi: 10.1002/rth2.12730. eCollection 2022 May.
9
Daily Monitoring of D-Dimer Allows Outcomes Prediction in COVID-19.
TH Open. 2021 Nov 30;6(1):e21-e25. doi: 10.1055/a-1709-5441. eCollection 2022 Jan.
10
Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients.
PLoS One. 2021 Sep 10;16(9):e0256931. doi: 10.1371/journal.pone.0256931. eCollection 2021.
本文引用的文献
1
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.
Lancet Respir Med. 2021 Jan;9(1):33-42. doi: 10.1016/S2213-2600(20)30417-3. Epub 2020 Oct 12.
2
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis.
Eur J Intern Med. 2020 Dec;82:29-37. doi: 10.1016/j.ejim.2020.09.006. Epub 2020 Sep 17.
3
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients.
Thromb Haemost. 2020 Dec;120(12):1720-1724. doi: 10.1055/s-0040-1715835. Epub 2020 Sep 1.
4
Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score).
Thromb Haemost. 2020 Dec;120(12):1716-1719. doi: 10.1055/s-0040-1715836. Epub 2020 Aug 30.
5
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.
Thromb Haemost. 2020 Dec;120(12):1668-1679. doi: 10.1055/s-0040-1715841. Epub 2020 Aug 24.
6
COVID-19 prediction models should adhere to methodological and reporting standards.
Eur Respir J. 2020 Sep 10;56(3). doi: 10.1183/13993003.02643-2020. Print 2020 Sep.
7
A Pathological Clarification of Sepsis-Associated Disseminated Intravascular Coagulation Based on Comprehensive Coagulation and Fibrinolysis Function.
Thromb Haemost. 2020 Sep;120(9):1257-1269. doi: 10.1055/s-0040-1713890. Epub 2020 Jul 17.
8
Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
Respir Res. 2020 Jul 3;21(1):169. doi: 10.1186/s12931-020-01428-7.
9
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30.
10
Dynamic relationship between D-dimer and COVID-19 severity.
Br J Haematol. 2020 Jul;190(1):e24-e27. doi: 10.1111/bjh.16811. Epub 2020 Jun 9.
Zotero 插件